Preconception Counseling in Primary Care Setting

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Preconception counseling is an important step in planning a pregnancy. It improves women’s reproductive health and increases the likelihood of a successful pregnancy. This article provides a detailed overview of the key issues to discuss with a primary care physician before trying to conceive, including plans to have children, current physical health status (such as chronic diseases and medication use), mental health status, and genetic status. Preconception counseling should include a timely medical examination to identify and address potential risks for future children. Special attention should be given to the preconception management of chronic diseases, such as diabetes mellitus and epilepsy. The article emphasized the important roles of psychological support and genetic counseling to minimize risks and prevent possible complications. In addition, the article discusses preventive measures such as infection screening, vaccinations, and lifestyle changes, including efforts to combat obesity and bad habits. These efforts should create optimal conditions for conception and healthy pregnancy. Therefore, preconception counseling is crucial to maintain women’s reproductive health and ensure the safety of expectant mothers and their children.

Full Text

Restricted Access

About the authors

Khusniddindzhon R. Ashurov

Bashkir State Medical University

Email: forib@inbox.ru
ORCID iD: 0009-0003-3216-8502
Russian Federation, Ufa

Shamil M. Abakarov

Rostov State Medical University

Author for correspondence.
Email: rsa005@bk.ru
ORCID iD: 0009-0001-7513-4818
Russian Federation, Rostov-on-Don

Anastasia A. Pukhova

Russian University of Medicine

Email: n.puxova@mail.ru
ORCID iD: 0009-0005-1748-8692
Russian Federation, Moscow

Elizaveta S. Sapogina

South Ural State Medical University

Email: sapogina_ls@mail.ru
ORCID iD: 0009-0005-7084-8175
Russian Federation, Chelyabinsk

Temur R. Gapirakhunov

Vernadsky Crimean Federal University

Email: dr.temur.gapirakhunovns@gmail.com
ORCID iD: 0009-0009-9959-6791
Russian Federation, Simferopol

Alina R. Kulenko

Rostov State Medical University

Email: alina.kulenko.a@yandex.ru
ORCID iD: 0009-0001-6872-5273
Russian Federation, Rostov-on-Don

Anastasia D. Solovushkova

Rostov State Medical University

Email: a.solovushkova@yandex.ru
ORCID iD: 0009-0007-9338-7855
Russian Federation, Rostov-on-Don

Svetlana Yu. Goncharova

Rostov State Medical University

Email: Kurochkina.swetaa1@yandex.ru
ORCID iD: 0009-0008-5178-2790
Russian Federation, Rostov-on-Don

Elizaveta S. Chernova

Rostov State Medical University

Email: liza.ruman@yandex.ru
ORCID iD: 0009-0001-2129-9369
Russian Federation, Rostov-on-Don

Alina A. Korban

Russian University of Medicine

Email: Korban.alya@list.ru
ORCID iD: 0009-0003-1002-468X
Russian Federation, Moscow

Aisylu V. Ardashirova

Bashkir State Medical University

Email: ionlywannabewithyou@vk.com
ORCID iD: 0009-0008-0316-4795
Russian Federation, Ufa

Liana V. Dinikaeva

Bashkir State Medical University

Email: dinikaeva01@mail.ru
ORCID iD: 0009-0009-4242-4040
Russian Federation, Ufa

Gulnaz R. Khabibova

Bashkir State Medical University

Email: gulnaz_khabibova@mail.ru
ORCID iD: 0009-0003-2681-7537
Russian Federation, Ufa

References

  1. Dobrokhotova IuÉ, Dzhokhadze LS. Preconception care as a real way to improve the perinatal outcomes. Russian Journal of Human Reproduction. 2019;25(6):38–43. (In Russ.) doi: 10.17116/repro20192506138
  2. Podilyakina YuS, Kulov DV, Amirbekova ZhT. Pregravidary preparation. Research and Practical Medicine Journal. 2021;8(2):83–89. (In Russ.) doi: 10.17709/2410-1893-2021-8-2-8
  3. Dorney E, Boyle JA, Walker R, et al. A systematic review of Clinical Guidelines for Preconception Care. Semin Reprod Med. 2022;40(3–04):157–169. doi: 10.1055/s-0042-1748190
  4. Stupak VS, Sokolovskaya TA, Postoev VA. Morbidity among parturient and postpartum women in the federal districts and constituent entities of the Russian Federation. Russian Journal of Preventive Medicine. 2021;24(9):17–23. doi: 10.17116/profmed20212409117
  5. Filippov OS, Guseva EV. Maternal mortality in the Russian Federation in 2020: the first year of the pandemic. Russian Journal of Human Reproduction. 2022;28(1):8–28. doi: 10.17116/repro2022280118
  6. Lassi ZS, Imam AM, Dean SV, Bhutta ZA. Preconception care: preventing and treating infections. Reprod Health. 2014;11(3):S4. doi: 10.1186/1742-4755-11-S3-S4
  7. Hussein N, Kai J, Qureshi N. The effects of preconception interventions on improving reproductive health and pregnancy outcomes in primary care: a systematic review. Eur J Gen Pract. 2016;22(1):42–52. doi: 10.3109/13814788.2015.1099039
  8. Bastani F, Hashemi S, Bastani N, Haghani H. Impact of preconception health education on health locus of control and self-efficacy in women. East Mediterr Health J. 2010;16(4):396–401.
  9. Hillemeier MM, Downs DS, Feinberg ME, et al. Improving women’s preconceptional health: findings from a randomized trial of the strong healthy women intervention in the Central Pennsylvania women’s health study. Womens Health Issues. 2008;18(6):S87–96. doi: 10.1016/j.whi.2008.07.008
  10. Dude AM, Schueler K, Schumm LP, et al. Preconception care and severe maternal morbidity in the United States. Am J Obstet Gynecol MFM. 2022;4(2):100549. doi: 10.1016/j.ajogmf.2021.100549
  11. Milovanov AP, Dobriakov AV. The increasing importance of extragenital pathology in the structure of maternal mortality in Russia. Russian Journal of Archive of Pathology. 2018;80(2):3–6. EDN: UPOJZH doi: 10.17116/patol20188023-6
  12. Bello JK, Rao G, Stulberg DB. Trends in contraceptive and preconception care in United States ambulatory practices. Fam Med. 2015;47(4):264–271.
  13. Hayes DK, Fan AZ, Smith RA, Bombard JM. Trends in selected chronic conditions and behavioral risk factors among women of reproductive age, behavioral risk factor surveillance system, 2001–2009. Prev Chronic Dis. 2011;8(6):A120.
  14. Shishcanu D, Marianian AY, Iliadi-Tulbure C. Preconceptional care: opportunities and challenges. Acta Biomed Sci. 2018;3(3):69–74. doi: 10.29413/ABS.2018-3.3.10
  15. Murphy M, McHugh S, O’Keeffe LM, et al. Preventive health counselling during antenatal care using the pregnancy risk assessment monitoring system (PRAMS) in Ireland. BMC Pregnancy Childbirth. 2020;20(1):98. doi: 10.1186/s12884-020-2756-y
  16. Cheng D, Schwarz EB, Douglas E, Horon I. Unintended pregnancy and associated maternal preconception, prenatal and postpartum behaviors. Contraception. 2009;79(3):194–198. doi: 10.1016/j.contraception.2008.09.009
  17. Bantyeva MN. The abortion problem situation in russia in 2008-2015 years. Obstetrics, Gynecology and Reproduction. 2016;10(3):47–52. EDN: WXFAKT doi: 10.17749/2313-7347.2016.10.2.047-052
  18. Allen D, Hunter MS, Wood S, Beeson T. One Key Question®: First things first in reproductive health. Matern Child Health J. 2017;21(3):387–392. doi: 10.1007/s10995-017-2283-2
  19. Zakharova TG. Contraception as the main method of family planning in the activity of general practitioner. Zemskiy vrach. 2015;3(27):5–11. (In Russ.) EDN: UKKTIH
  20. Ni W, Gao X, Su X, et al. Birth spacing and risk of adverse pregnancy and birth outcomes: A systematic review and dose-response meta-analysis. Acta Obstet Gynecol Scand. 2023;102(12):1618–1633. doi: 10.1111/aogs.14648
  21. Hanley GE, Hutcheon JA, Kinniburgh BA, Lee L. Interpregnancy interval and adverse pregnancy outcomes: an analysis of successive pregnancies. Obstet Gynecol. 2017;129(3):408–415. doi: 10.1097/AOG.0000000000001891
  22. Schummers L, Hutcheon JA, Hernandez-Diaz S, et al. Association of short interpregnancy interval with pregnancy outcomes according to maternal age. JAMA Intern Med. 2018;178(12):1661–1670. doi: 10.1001/jamainternmed.2018.4696
  23. Mukhamadieva SM, Olimova FA, Rustamova MS, Pulatova AP. Medical and social aspects of reproductive health of women with disabilities with disabilities of the musculoskeletal system. Medical Bulletin of the National Academy of Sciences of Tajikistan. 2020;10(33):62–70. EDN: VFGHHN doi: 10.31712/2221-7355-2020-10-1-62-70
  24. König-Bachmann M, Zenzmaier C, Schildberger B. Health professionals’ views on maternity care for women with physical disabilities: a qualitative study. BMC Health Serv Res. 2019;19(1):551. doi: 10.1186/s12913-019-4380-y
  25. Iezzoni LI, Mitra M. Transcending the counter-normative: Sexual and reproductive health and persons with disability. Disabil Health J. 2017;10(3):369–370. doi: 10.1016/j.dhjo.2017.04.001
  26. Sibirskaya EV, Blinnikova ES. Diabetes mellitus and pregnancy (literature review). Russian Journal of Human Reproduction. 2020;26(6):122–130. EDN: AXOOHA doi: 10.17116/repro202026061122
  27. Chen X, Zhang Y, Chen H, et al. Association between serum glycated hemoglobin levels at early gestation and the risk of subsequent pregnancy loss in pregnant women without diabetes mellitus: prospective cohort study. JMIR Public Health Surveill. 2023;9:e46986. doi: 10.2196/46986
  28. Xiong W, Han L, Tang X, et al. Preconception blood pressure and adverse pregnancy outcomes: a population-based cohort study. Hypertension. 2024;81(4):e31–e40. doi: 10.1161/HYPERTENSIONAHA.123.22296
  29. Ziganshin AM, Kulavski VA, Vashkevich AG. Pregnancy and epilepsy. Russian Bulletin of Obstetrician-Gynecologist. 2019;19(3):43–48. EDN: IZDJSA doi: 10.17116/rosakush20191903143
  30. Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association. Circulation. 2021;143(18):e902–e916. doi: 10.1161/CIR.0000000000000961
  31. Chighizola CB, Clowse M, Meroni PL, et al. The SPROUT study: A survey on current management practice of reproductive aspects in women of childbearing age with systemic autoimmune rheumatic diseases. Autoimmun Rev. 2023;22(8):103376. doi: 10.1016/j.autrev.2023.103376
  32. Verbiest S, Cené C, Chambers E, et al. Listening to patients: Opportunities to improve reproductive wellness for women with chronic conditions. Health Serv Res. 2022;57(6):1396–1407. doi: 10.1111/1475-6773.14082
  33. Steel A, Lucke J, Adams J. The prevalence and nature of the use of preconception services by women with chronic health conditions: an integrative review. BMC Womens Health. 2015;15:14. doi: 10.1186/s12905-015-0165-6
  34. Goossens J, De Roose M, Van Hecke A, et al. Barriers and facilitators to the provision of preconception care by healthcare providers: a systematic review. Int J Nurs Stud. 2018;87:113–130. doi: 10.1016/j.ijnurstu.2018.06.009
  35. Birru Talabi M, Callegari LS, Kazmerski TM, et al. A blueprint for a new model of sexual and reproductive health care in subspecialty medicine. Health Serv Res. 2023;58(1):216–222. doi: 10.1111/1475-6773.14074
  36. Hassan A, Yates L, Hing AK, et al. Dobbs and disability: Implications of abortion restrictions for people with chronic health conditions. Health Serv Res. 2023;58(1):197–201. doi: 10.1111/1475-6773.14108
  37. Evstifeeva SE, Shalnova SA, Kutsenko VA, et al. Anxiety and depression: ten-year changes of prevalence and its association with demographic and socio-economic characteristics according to the ESSE-RF study. Cardiovascular Therapy and Prevention. 2023;22(8S):3796. doi: 10.15829/1728-8800-2023-3796
  38. Ozcan NK, Boyacıoğlu NE, Enginkaya S, et al. Reproductive health in women with serious mental illnesses. J Clin Nurs. 2014;23(9–10):1283–1291. doi: 10.1111/jocn.12332
  39. Nicholson WK, Setse R, Hill-Briggs F, et al. Depressive symptoms and health-related quality of life in early pregnancy. Obstet Gynecol. 2006;107(4):798–806. doi: 10.1097/01.AOG.0000204190.96352.05
  40. Miller ES, Saade GR, Simhan HN, et al. Trajectories of antenatal depression and adverse pregnancy outcomes. Am J Obstet Gynecol. 2022;226(1):108.e1–108.e9. doi: 10.1016/j.ajog.2021.07.007
  41. Thiele GA, Ryan DM, Oberlander TF, Hanley GE. Preconception mental health and the relationship between antenatal depression or anxiety and gestational diabetes mellitus: a population-based cohort study. BMC Pregnancy Childbirth. 2022;22(1):670. doi: 10.1186/s12884-022-05002-5
  42. Packer CH, Pilliod RA, Chatroux LR, et al. Increased rates of adverse perinatal outcomes in women with gestational diabetes and depression. J Matern Fetal Neonatal Med. 2021;34(23):3862–3866. doi: 10.1080/14767058.2019.1701647
  43. Perova EI, Stenyaeva NN, Apolikhina IA. Pregnancy in the presence of anxiety and depressive conditions. Obstetrics and gynecology. 2013;(6):23–27. EDN: QLIKYF
  44. Stein A, Pearson RM, Goodman SH, et al. Effects of perinatal mental disorders on the fetus and child. Lancet. 2014;384(9956):1800–1819. doi: 10.1016/S0140-6736(14)61277-0
  45. US Preventive Services Task Force; Barry MJ, Nicholson WK, et al. Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(24):2163–2170. doi: 10.1001/jama.2023.9301
  46. O’Connor EA, Henninger ML, Perdue LA, et al. Anxiety screening: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2023;329(24):2171–2184. doi: 10.1001/jama.2023.6369
  47. US Preventive Services Task Force; Barry MJ, Nicholson WK, et al. Screening for depression and suicide risk in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(23):2057–2067. doi: 10.1001/jama.2023.9297
  48. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x
  49. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi: 10.1001/archinte.166.10.1092
  50. Levis B, Sun Y, He C, et al. Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression: systematic review and meta-analysis. JAMA. 2020;323(22):2290–2300. doi: 10.1001/jama.2020.6504
  51. Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284–1292. doi: 10.1097/01.MLR.0000093487.78664.3C
  52. Anderson KN, Lind JN, Simeone RM, et al. Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects. JAMA Psychiatry. 2020;77(12):1246–1255. doi: 10.1001/jamapsychiatry.2020.2453
  53. Gao SY, Wu QJ, Sun C, et al. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. 2018;16(1):205. doi: 10.1186/s12916-018-1193-5
  54. US Preventive Services Task Force; Curry SJ, Krist AH, et al. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(18):1899–1909. doi: 10.1001/jama.2018.16789
  55. Patnode CD, Perdue LA, Rushkin M, et al. Screening for unhealthy drug use: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2020;323(22):2310–2328. doi: 10.1001/jama.2019.21381
  56. Klimkiewicz A, Jakubczyk A, Mach A, et al. Psychometric properties of the polish version of the Alcohol Use Disorders Identification Test (AUDIT). Drug Alcohol Depend. 2021;218:108427. doi: 10.1016/j.drugalcdep.2020.108427
  57. Sokol RJ, Martier SS, Ager JW. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol. 1989;160(4):863–868; discussion 868–870. doi: 10.1016/0002-9378(89)90302-5
  58. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;131(10):1121–1123. doi: 10.1176/ajp.131.10.1121
  59. Fedorova SS. Characteristics of substance use disorders among women. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(5 Pt 2):15–20. (In Russ.)
  60. Ryan KS, Prewitt KC, Hayer S, et al. Opioid use in pregnancy: a review. Obstet Gynecol Surv. 2023;78(1):35–49. doi: 10.1097/OGX.0000000000001094
  61. Jones HE, Martin PR, Heil SH, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat. 2008;35(3):245–259. doi: 10.1016/j.jsat.2007.10.007
  62. Siddiqi AD, Chen TA, Britton M, et al. Changes in substance use treatment providers’ delivery of the 5a’s for non-cigarette tobacco use in the context of a comprehensive tobacco-free workplace program implementation. Int J Environ Res Public Health. 2023;20(3):2730. doi: 10.3390/ijerph20032730
  63. Havard A, Chandran JJ, Oei JL. Tobacco use during pregnancy. Addiction. 2022;117(6):1801–1810. doi: 10.1111/add.15792
  64. Fanshawe TR, Halliwell W, Lindson N, et al. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2017;11(11):CD003289. doi: 10.1002/14651858.CD003289.pub6
  65. US Preventive Services Task Force; Krist AH, Davidson KW, et al. Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(3):265–279. doi: 10.1001/jama.2020.25019
  66. Committee opinion No. 691: carrier screening for genetic conditions. Obstet Gynecol. 2017;129(3):e41–e55. doi: 10.1097/AOG.0000000000001952
  67. Frigon MP, Lavoie M, Emond MJ, et al. Family planning decisional needs assessment for recessive hereditary disorders: Insights from carrier couples and professionals. Patient Educ Couns. 2022;105(7):2537–2545. doi: 10.1016/j.pec.2021.11.027
  68. Pivazyan LG, Unanyan AL, Davydova JuD, et al. Cervical cancer prevention and screening: a review of international clinical guidelines. Russian Journal of Human Reproduction. 2022;28(5):90–99. EDN: SCTXVS doi: 10.17116/repro20222805190
  69. Kolyadina IV, Poddubnaya IV, Komov DV. Breast cancer screening: world experience and prospects. Russian Journal of Oncology. 2015;20(1):42–46. EDN: TSKRQT doi: 10.17816/onco40145
  70. ACOG committee opinion No. 762: Prepregnancy counseling. Obstet Gynecol. 2019;133(1):e78–e89. doi: 10.1097/AOG.0000000000003013
  71. Namazova-Baranova LS, Fedoseenko MV, Selimzyanova LR, et al. Modern approaches in immunoprophylaxis of infectious diseases during pregnancy. Pediatric pharmacology. 2022;19(5):417–423. doi: 10.15690/pf.v19i5.2487
  72. Guidelines for Vaccinating Pregnant Women [Internet]. CDC. Pregnancy and Vaccination. July. 18, 2024. Available from: https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html. Accessed: 18 May 2025.
  73. Batyukova VE. Domestic violence. Problems and solutions. Zakon i pravo. 2021;(1):83–85. EDN: FEIOBJ doi: 10.24412/2073-3313-2021-1-83-85
  74. Miller E, Decker MR, McCauley HL, et al. Pregnancy coercion, intimate partner violence and unintended pregnancy. Contraception. 2010;81(4):316–322. doi: 10.1016/j.contraception.2009.12.004
  75. US Preventive Services Task Force; Curry SJ, Krist AH, et al. Screening for intimate partner violence, elder abuse, and abuse of vulnerable adults: US Preventive Services Task Force Final Recommendation Statement. JAMA. 2018;320(16):1678–1687. doi: 10.1001/jama.2018.14741
  76. Rabin RF, Jennings JM, Campbell JC, Bair-Merritt MH. Intimate partner violence screening tools: a systematic review. Am J Prev Med. 2009;36(5):439–445.e4. doi: 10.1016/j.amepre.2009.01.024
  77. Davis M, Padilla-Medina DM. Brief intimate partner violence perpetration screening tools: a scoping review. Trauma Violence Abuse. 2021;22(4):900–913. doi: 10.1177/1524838019888545
  78. Andreeva EN, Sheremetyeva EV, Fursenko VA. Obesity – threat to the reproductive potential of Russia. Obesity and metabolism. 2019;16(3):20–28. EDN: SNJRHQ doi: 10.14341/omet10340
  79. Kwong W, Tomlinson G, Feig DS. Maternal and neonatal outcomes after bariatric surgery; a systematic review and meta-analysis: do the benefits outweigh the risks? Am J Obstet Gynecol. 2018;218(6):573–580. doi: 10.1016/j.ajog.2018.02.003
  80. Andreeva EN, Absatarova YuS, Sheremetyeva EV, Fursenko VA. Obesity and reproductive function of women: epigenetic and somato-psychological features. Obesity and metabolism. 2019;16(2):9–15. EDN: MDQXIQ doi: 10.14341/omet10113
  81. Guardado-Mendoza R, Salazar-López SS, Álvarez-Canales M, et al. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial. Metabolism. 2020;104:154054. doi: 10.1016/j.metabol.2019.154054
  82. Vitek WS, Hoeger KM. Worth the wait? Preconception weight reduction in women and men with obesity and infertility: a narrative review. Fertil Steril. 2022;118(3):447–455. doi: 10.1016/j.fertnstert.2022.07.001
  83. Leskova IV, Ershova EV, Nikitina EA, et al. Obesity in Russia: modern view in the light of a social problems. Obesity and metabolism. 2019;16(1):20–26. EDN: KDEROH doi: 10.14341/omet9988
  84. Hill B, Azzari Wynn-Jones A, Botting KJ, et al. The challenge of weight stigma for women in the preconception period: workshop recommendations for action from the 5th European Conference on Preconception Health and Care. Int J Environ Res Public Health. 2023;20(22):7034. doi: 10.3390/ijerph20227034
  85. Hill B, Incollingo Rodriguez AC. Weight stigma across the preconception, pregnancy, and postpartum periods: a narrative review and conceptual model. Semin Reprod Med. 2020;38(6):414–422. doi: 10.1055/s-0041-1723775
  86. Welsh S, Salazar-Collier C, Blakeslee B, et al. Comparison of obstetrician-gynecologists and family physicians regarding weight-related attitudes, communication, and bias. Obes Res Clin Pract. 2021;15(4):351–356. doi: 10.1016/j.orcp.2021.04.010
  87. Lichtenstein AH, Appel LJ, Vadiveloo M, et al. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2021;144(23):e472–e487. doi: 10.1161/CIR.0000000000001031
  88. Bakhareva IV. Modern pregravidary preparation: an integrated approach. Russian journal of woman and child health. 2017;25(12):889–894. EDN: ZMYNGT
  89. Gascoigne EL, Webster CM, Honart AW, et al. Physical activity and pregnancy outcomes: an expert review. Am J Obstet Gynecol MFM. 2023;5(1):100758. doi: 10.1016/j.ajogmf.2022.100758
  90. Nystoriak MA, Bhatnagar A. Cardiovascular effects and benefits of exercise. Front Cardiovasc Med. 2018;5:135. doi: 10.3389/fcvm.2018.00135
  91. Buck Louis GM, Sapra KJ, Schisterman EF, et al. Lifestyle and pregnancy loss in a contemporary cohort of women recruited before conception: The LIFE Study. Fertil Steril. 2016;106(1):180–188. doi: 10.1016/j.fertnstert.2016.03.009
  92. Normal pregnancy (2023). Clinical guidelines [Internet]. Available from: https://srb-48.gosuslugi.ru/netcat_files/44/136/KR_Normal_naya_beremennost_.pdf. Accessed: 18 May 2025. (In Russ.)
  93. Ren M, Shireman H, VanGompel EW, et al. Preconception, Interconception, and reproductive health screening tools: a systematic review. Health Serv Res. 2023;58(2):458–488. doi: 10.1111/1475-6773.14123

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 70763 от 21.08.2017 г.